Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still\textquoterights disease
(1, 2)
,
(3, 4)
,
,
(5)
,
,
(6)
,
(7)
,
(8)
,
(9)
,
(10, 11, 12)
,
(13)
,
,
,
,
,
,
1
2
3
4
5
6
7
8
9
10
11
12
13
2
3
4
5
6
7
8
9
10
11
12
13
Bruno Fautrel
- Function : Author
- PersonId : 759312
- ORCID : 0000-0001-8845-4274
Jürgen Rech
- Function : Author
Eugen Feist
- Function : Author
Jacques Morel
- Function : Author
- PersonId : 762356
- ORCID : 0000-0001-7545-6385
Thierry Schaeverbeke
- Function : Author
- PersonId : 756185
- ORCID : 0000-0002-6976-643X
Thierry Martin
- Function : Author
- PersonId : 1647
- IdHAL : thierry-martin
- IdRef : 170408108
Bernhard Hellmich
- Function : Author
Peter Lamprecht
- Function : Author
Hendrik Schulze-Koops
- Function : Author
Delphine Sophie Courvoisier
- Function : Author
- PersonId : 775513
- ORCID : 0000-0002-1956-2607
Andrew Sleight
- Function : Author
Eduardo Jorge Schiffrin
- Function : Author